Abstract
Several families of short and long interspersed DNA elements (SINEs and LINEs) inhabit mammalian genomes. Amplification of these elements (which can exceed one million copies) has occurred primarily by an RNA-mediated mechanism referred to as retroposition (or retrotransposition). When integrated into a gene, these elements may cause deleterious effects to the individual organism, as exemplified in various human disorders. Alternatively, several integration-recipient genes with altered function or expression are evolutionarily conserved within or among species. Experimental analyses further demonstrate effects of gene regulation by retroposed elements. Although most integrations apparently have no significant impact on the phenotype of various mammalian species, the accumulation of SINEs and LINEs provides a multitude of sites for homologous recombination and yields a considerable proportion of methylation sites in mammalian genomes. Specific and cumulative integrations may provide an integral component in the speciation process. This review examines the functional and regulatory impact of retroposon integrations on individual genes, the impact of accumulated integration events, and the evidence for the role of these elements in the evolution of species. Since these elements continue to integrate into mammalian genomes, it is important to further understand and evaluate their functional impact.
Keywords: SINEs, LINEs, Neurofibromatosis, Apert Syndrome, Alport Syndrome, Gyrate Atrophy of Choroid, Spastic, Canine Transmissible venereal tumor, Hemophilia
Current Genomics
Title: Impact of SINEs and LINEs on the Mammalian Genome
Volume: 2 Issue: 2
Author(s): H. D. Kass
Affiliation:
Keywords: SINEs, LINEs, Neurofibromatosis, Apert Syndrome, Alport Syndrome, Gyrate Atrophy of Choroid, Spastic, Canine Transmissible venereal tumor, Hemophilia
Abstract: Several families of short and long interspersed DNA elements (SINEs and LINEs) inhabit mammalian genomes. Amplification of these elements (which can exceed one million copies) has occurred primarily by an RNA-mediated mechanism referred to as retroposition (or retrotransposition). When integrated into a gene, these elements may cause deleterious effects to the individual organism, as exemplified in various human disorders. Alternatively, several integration-recipient genes with altered function or expression are evolutionarily conserved within or among species. Experimental analyses further demonstrate effects of gene regulation by retroposed elements. Although most integrations apparently have no significant impact on the phenotype of various mammalian species, the accumulation of SINEs and LINEs provides a multitude of sites for homologous recombination and yields a considerable proportion of methylation sites in mammalian genomes. Specific and cumulative integrations may provide an integral component in the speciation process. This review examines the functional and regulatory impact of retroposon integrations on individual genes, the impact of accumulated integration events, and the evidence for the role of these elements in the evolution of species. Since these elements continue to integrate into mammalian genomes, it is important to further understand and evaluate their functional impact.
Export Options
About this article
Cite this article as:
Kass D. H., Impact of SINEs and LINEs on the Mammalian Genome, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013350968
DOI https://dx.doi.org/10.2174/1389202013350968 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Current Medicinal Chemistry Immuno-Isolation in Cancer Gene Therapy
Current Gene Therapy Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial
Reviews on Recent Clinical Trials Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Sera/Organ Lysates of Selected Animals Living in Polluted Environments Exhibit Cytotoxicity against Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Magnetite Nanostructures with Applications in Cancer Therapy
Current Proteomics Comparison of Large Proteomic Datasets
Current Proteomics Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics
Current Drug Targets Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter
Current Cancer Drug Targets Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment
Current Cancer Drug Targets Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Current Pharmaceutical Design Comparison of Kernel and Decision Tree-based Algorithms for the Prediction of microRNAs Associated with Cancer
Current Bioinformatics Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
Current Pharmaceutical Design Drug Metabolite Generation Using a Laboratory Evolved NADPH Independent Cytochrome P450: Application of in vitro and in silico Approaches
Drug Metabolism Letters The Nutrigenetics and Pharmacogenetics of Vitamin D Pathways
Current Pharmacogenomics and Personalized Medicine Helenalin - A Sesquiterpene Lactone with Multidirectional Activity
Current Drug Targets Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders-Drug Targets